Study of Interleukin 6 in Rheumatoid Arthritis and Anemic Patients in Sudan

Samar Mirghani Sidahmed Osman; Olla Mirghani Seidahmed Osman; Ibrahim Khidir Ibrahim

doi:10.32628/IJSRSET24115119

Authors

Samar Mirghani Sidahmed Osman Department of Hematology, Faculty of Medical Laboratory Sciences University of Al-Neelin, Khartoum, Sudan Author
Olla Mirghani Seidahmed Osman Department of Zoology, Faculty of Science, University of Khartoum, Khartoum, Sudan Author
Ibrahim Khidir Ibrahim Department of Hematology, Faculty of Medical Laboratory Sciences University of Al-Neelin, Khartoum, Sudan Author

DOI:

https://doi.org/10.32628/IJSRSET24115119

Keywords:

Anemia, Hepcidin, Rheumatoid Arthritis, Interleukin-6, Blood Parameters

Abstract

Rheumatoid arthritis is considered one of the most common, and particularly attacks the joint causing significant individual and community burden and resulting from immunological abnormalities. It has been found that IL-6 plays a key role in the development of this disease. Overall anemia of chronic disease and iron deficiency anemia are frequent causes of anemia in RA patients. This study to analysis serum IL6 and to detect frequency of anemia/non-anemia and Rheumatoid arthritis (RA) patients and establish relationship between blood parameters and disease activity among Sudanese patients suffering from rheumatoid arthritis and deficiency anemia in Khartoum State.

Methods

It is a descriptive case-control study that involved 74 patients of both genders of RA, Anemia and non-anemic disease duration was two years. This study was conducted in Khartoum State. Complete Blood Count (CBC) was performed using the Auto Hematology Analyzer. Serum concentrations of IL-6, was measured in all patients and healthy individual using CLIA. The data collection was simple questionnaire and self-interview.

Results

The frequency of the RA within anemic and non- anemic patients was found higher in females 46(62.16%) than in males 28(37.83%). The overall analysis showed significant changes in most of blood parameters between the age groups. A statistically significant association was found between the WBCs, RBCs and MCH blood parameters with IL6 among RA/anemia's patients with Chi square p-value = 0.001,0.013 and 0.014, respectively. The statistic odd ratio was found 5.828 and 5.703 for WBCs and RBCs. This increase was highly significant among RA-Anemia patients in particular.

Conclusion

Our study reported the blood parameters isolates which harbored the IL6 and their association with rheumatoid arthritis and Anaemia which possibly cause the disease symptoms. Anemia is an important complication in rheumatoid arthritis (RA) which is associated with physical disability and increased mortality. Among various mechanisms, recent studies suggest the central role of hepcidin and IL-6 for the pathophysiology of Anemia.

Downloads

Download data is not yet available.

References

Andrea Rubbert-Roth , Daniel E Furst , Stefano Fiore , Amy Praestgaard , Vivian Bykerk , Clifton O Bingham 5, Christina Charles-Schoeman , Gerd Burmester. 2022. Association between low hemoglobin, clinical measures, and patient-reported outcomes in patients with rheumatoid arthritis: results from post hoc analyses of three phase III trials of sarilumab. 25;24(1):207.doi: 10.1186/s13075-022-02891-x. DOI: https://doi.org/10.1186/s13075-022-02891-x

Y. Yoshida and T.Tanaka.2013. Interleukin 6 and Rheumatoid Arthritis. Toshio Tanaka; ttanak@imed3.med.osaka-u.ac.jp DOI: https://doi.org/10.1155/2014/698313

Georg Schett 2018. Physiological effects of modulating the interleukin-6 axis. doi:10.1093/rheumatology/kex513. DOI: https://doi.org/10.1093/rheumatology/kex513

Toshio Tanaka, Masashi Narazaki, and Tadamitsu Kishimoto (2014). I L-6 in Inflammation, Immunity, and Disease; doi: 10.1101/cshperspect.a016295 DOI: https://doi.org/10.1101/cshperspect.a016295

Bing Li (MD, PhD), Yu Xiao (MD, PhD), Dan Xing (MD, PhD), Xin-long Ma (MD, PhD), Jun Liu (MD, PhD) 2016.circulating interleukin-6 and rheumatoid arthritis A Mendelian randomization meta-analysis.

Combe B. 2009. Progression in early rheumatoid arthritis. Best Pract Res Clin Rheumatol. doi;23:59–69. [PubMed] [Google Scholar] DOI: https://doi.org/10.1016/j.berh.2008.11.006

Warqaa khalaf, Haithem Ahmed Al-Rubaie and Sami shihab. (2019). Studying Anemia of Chronic Disease and Iron Deficiency in Patients with Rheumatoid Arthritis by Iron Status and Circulating Hepcidin. Doi.org/10.4081/hr.2019.11(1),7708. DOI: https://doi.org/10.4081/hr.2019.7708

A. J. Madu and M. D. Ughasoro. (2017). Anaemia of chronic disease: an in-depth review,” Medical Principles and Practice, vol. 26, no. 1, pp. 1–9. View at Publisher · View at Google Scholar · View at Scopus DOI: https://doi.org/10.1159/000452104

Guenter Weiss, M.D., and Lawrence T. Goodnough, M.D. (2005). Anemia of Chronic Disease NEngl J Med 2005;352:1011-23 DOI: https://doi.org/10.1056/NEJMra041809

Eman Tariq Ali, 1 Azza Sajed Jabbar,2 and Ali Nazar Mohammed3A.(2019). Comparative Study of Interleukin 6, Inflammatory Markers, Ferritin, and Hematological Profile in Rheumatoid Arthritis Patients with Anemia of Chronic Disease and Iron Deficiency Anemia. https://doi.org/10.1155/2019/3457347 DOI: https://doi.org/10.1155/2019/3457347

Rasha Abdel-noor, Abo Zaid MH, Elshweikh SA and et. al. 2019. The Importance of Log Ferritin and Transferrin /Log Ferritin in Differentiating Iron Deficiency Anemia from Anemia of Chronic Disease in Rheumatoid Arthritis Patients.26(1):141-150.PMID:31333004.

M. Hashimoto ,T. Fujii, M. Hamaguchi, M. Furu, et.al. Increase of Hemoglobin Levels by Anti-IL-6 Receptor Antibody (Tocilizumab) in Rheumatoid Arthritis (2014) doi.org/10.1371/journal.pone.0098202. PMC4039447. DOI: https://doi.org/10.1371/journal.pone.0098202

Tahani Mursal, Sahar Elbager, Abubaker Fadl Elmola, Rania Ahmed, Mahir Mohamed, Tahani Abbas. 2016. DIFFERENTIAL DIAGNOSIS OF ANEMIA IN RHEUMATOID ARTHRITIS SUDANESE PATIENTS.

Safa K Abdelsalam , Nada T Hashim end et.al (2011). Periodontal status of rheumatoid arthritis patients in Khartoum State. http://www.biomedcentral.com/1756-0500/4/460 DOI: https://doi.org/10.1186/1756-0500-4-460

K. Schinnerling,* † J. C. Aguillon, * † D. Catalan * † and L. Soto (2017) The role of interleukin-6 signalling and its therapeutic blockage in skewing the T cell balance in rheumatoid arthritis. doi:10.1111/cei.12966. DOI: https://doi.org/10.1111/cei.12966

Anca BOBIRCA, Anca-Teodora FLORESCU1, Cristina ALEXANDRU1, Florin-Teodor BOBIRCA2, et al. 2022. Characteristics of Anemia in Rheumatoid Arthritis. Vol. 29, No.

Birch JT Jr, Bhattacharya S. Emerging trends in diagnosis and treatment of rheumatoid arthritis. Prim Care. 2010;37:779–92. [PubMed] [Google Scholar] DOI: https://doi.org/10.1016/j.pop.2010.07.001

C. Georganas, H. Liu, H.Perlman, A. Hoffmann, B. Thimmapaya and R. M. Pope. 2019. Regulation of IL-6 and IL-8 Expression in Rheumatoid Arthritis Synovial Fibroblasts: The Dominant Role for NF-κB But Not C/EBP β or c-Jun. doi: 10.4049/jimmunol.165.12.7199. DOI: https://doi.org/10.4049/jimmunol.165.12.7199

Symmons DP, Barrett EM, Bankhead CR, Scott DG, Silman AJ: (1994).The incidence of rheumatoid arthritis in the United Kingdom: Results from the Norfolk Arthritis Register. Br J Rheumatol, 33:735-739. DOI: https://doi.org/10.1093/rheumatology/33.8.735

W. Kullich, F. Niksic, K. Burmucic, G. Pöllmann, and G. Klein, “Effects of the chemokine MIP-1α on anemia and inflammation in rheumatoid arthritis,” Zeitschrift für Rheumatologie, vol. 61, no. 5, pp. 568–576, 2002. View at Publisher · View at Google Scholar · View at Scopus. DOI: https://doi.org/10.1007/s00393-002-0410-x

Muaz. Abd El Latif. M 2004.PRESENTATION AND MANAGEMENT OF PATIENTS WITH SEROPOSITIVE RHEUMATOID ARTHRITIS IN KHARTOUM STATE.

Lee DM, Weinblatt ME: (2001). Rheumatoid arthritis. Lancet, 358:903-911 DOI: https://doi.org/10.1016/S0140-6736(01)06075-5

R.J.Simpson, A.Hammacher, D. K. Smith, J. M. Matthews, and L. D Ward(1997). Interleukin-6: structure= function relationships. Doi:10.1002/pro.5560060501. DOI: https://doi.org/10.1002/pro.5560060501

E. Poggiali, M. Migone De Amicis, and I. Motta, “Anemia of chronic disease: A unique defect of iron recycling for many different chronic diseases,” European Journal of Internal Medicine, vol. 25, no. 1, pp. 12–17, 2014. View at Publisher · View at Google Scholar · View at Scopus. DOI: https://doi.org/10.1016/j.ejim.2013.07.011

S. Akira, T. Taga, and T. Kishimoto, “Interleukin-6 in biology and medicine,” Advances in Immunology, vol. 54, pp. 1–78, 1993. View at Publisher · View at Google Scholar. DOI: https://doi.org/10.1016/S0065-2776(08)60532-5

M. Romano, M. Sironi, C. Toniatti et al., “Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment,” Immunity, vol. 6, no. 3, pp. 315–325, 1997. View at Publisher · View at Google Scholar · View at Scopus. DOI: https://doi.org/10.1016/S1074-7613(00)80334-9

J. Przybyszewska, E. Zekanowska, K. Kȩdziora-Kornatowska, J. Boinska, R. Cichon, and K. Porzych, “Serum prohepcidin and other iron metabolism parameters in elderly patients with anemia of chronic disease and with iron defciency anemia,” Polskie Archiwum Medycyny Wewnętrznej, vol. 123, no. 3, pp. 105–111, 2013. View at Google Scholar · View at Scopus. DOI: https://doi.org/10.20452/pamw.1623

M. Hashizume and M. Mihara, “The roles of interleukin-6 in the pathogenesis of rheumatoid arthritis,” Arthritis & Rheumatology, vol. 2011, Article ID 765624, 8 pages, 2011. View at Publisher · View at Google Scholar. DOI: https://doi.org/10.1155/2011/765624

Sabau A, Craciun A, Gabriela C, et al. Association between acute phase reactant levels, and disease activity score (DAS28) in patients with rheumatoid arthritis and anemia, revista românã de reumatologie – VOL. XX NR. 4, An 2011. 2

papadaki HA, Kritikos HD, Valatas V, et al. Anaemia of chronic disease in rheumatoid arthritis is associated with increased apoptosis of bone marrow erythroid cells: improvement following anti-tumor necrosis factor-a antibody therapy 2002; 100:474-482. DOI: https://doi.org/10.1182/blood-2002-01-0136

Agrawal S, Misra R, Aggarwal A. 2006. Anemia in rheumatoid arthritis. High prevalence of iron-deficiency anemia in Indian patients. 26(12)1091-5. Doi: 10.1007/s00296-006-0133-4.Epub. DOI: https://doi.org/10.1007/s00296-006-0133-4

Nikolaisen C, Figenschau Y, Nossent JC. Anemia in early rheumatoid arthritis is associated with interleukin 6-mediated bone marrow suppression, but has no effect on disease course or mortality. J Rheumatol 2008; 35:380-386.

Usman Ali, Muddasar Hussain Bilal Mukhtar. 2018. Different Manifestations of Anemia in Rheumatoid Arthritis patients. ISSN 2349-7750. 05 (11), 13259-13246.

Theurl, V. Mattle, M. Seifert, M. Mariani, C. Marth, and G. Weiss. 2006. Dysregulated monocyte iron homeostasis and erythropoietin formation in patients with anemia of chronic disease,” Blood, vol. 107, no. 10, pp. 4142–4148, 2006. View at Publisher · View at Google Scholar · View at Scopus . DOI: https://doi.org/10.1182/blood-2005-08-3364